Doctor Clotilde Roy
Jolimont Lobbes Hospital, La Louviere (Belgium)
Fibroblast growth factor 23 and extracellular volume as markers of myocardial fibrosis and poor outcome in heart failure with preserved ejection fraction
Event: ESC Congress 2018
Topic: Biomarkers
Session: Exploring biomarkers in heart failure
Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
Event: ESC Congress 2018
Topic: Biomarkers
Session: Exploring biomarkers in heart failure
Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction
Event: Heart Failure 2018
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography
Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.
Event: Heart Failure 2018
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Moderated Poster session 1 - Diagnosis and biomarkers
Age and gender interaction with t1, t2, t2* and extracellular volume reference values in healthy volunteers at 3 tesla cardiac magnetic resonance.
Event: EuroCMR 2017
Topic: Cardiac Magnetic Resonance
Session: Oral abstract session 4
ESC 365 is supported by
